121 related articles for article (PubMed ID: 15319323)
1. Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE; Pandian R
Clin Chem; 2004 Oct; 50(10):1804-8. PubMed ID: 15319323
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
[TBL] [Abstract][Full Text] [Related]
3. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for down syndrome: preliminary results of an observational study on fresh samples.
Palomaki GE; Knight GJ; Roberson MM; Cunningham GC; Lee JE; Strom CM; Pandian R
Clin Chem; 2004 Jan; 50(1):182-9. PubMed ID: 14709646
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
Palomaki GE; Knight GJ; Neveux LM; Pandian R; Haddow JE
Clin Chem; 2005 Aug; 51(8):1499-504. PubMed ID: 15961547
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-deficient invasive trophoblast antigen (sd-ITA): a new urinary variant for gestational Down syndrome screening.
Sutton JM; Cole LA
Prenat Diagn; 2004 Mar; 24(3):194-7. PubMed ID: 15057952
[TBL] [Abstract][Full Text] [Related]
6. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities.
Weinans MJ; Butler SA; Mantingh A; Cole LA
Prenat Diagn; 2000 Dec; 20(12):976-8. PubMed ID: 11113909
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Palomaki GE; Neveux LM; Haddow JE; Wyatt P
Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
[TBL] [Abstract][Full Text] [Related]
8. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
9. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
Spencer K; Talbot JA; Abushoufa RA
Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
[TBL] [Abstract][Full Text] [Related]
11. Free beta-hCG subunit versus intact hCG in Down syndrome screening.
Wenstrom KD; Owen J; Chu DC; Boots L
Obstet Gynecol; 1997 Sep; 90(3):370-4. PubMed ID: 9277646
[TBL] [Abstract][Full Text] [Related]
12. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
[TBL] [Abstract][Full Text] [Related]
13. Practical strategies in contingent sequential screening for Down syndrome.
Benn P; Wright D; Cuckle H
Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
[TBL] [Abstract][Full Text] [Related]
14. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
16. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
17. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
18. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
19. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
20. First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG.
Hallahan T; Krantz D; Orlandi F; Rossi C; Curcio P; Macri S; Larsen J; Buchanan P; Macri J
Prenat Diagn; 2000 Oct; 20(10):785-9;discussion 790-1. PubMed ID: 11038453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]